Description
PF-06939999 is a SAM-competitve inhibitor of PRMT5.
| Product Unit Size | Cost | Quantity | Stock |
|---|
PF-06939999 is a SAM-competitve inhibitor of PRMT5.
| Cas No. | 2159123-14-3 |
|---|---|
| Purity | ≥98% |
| Formula | C22H23F3N4O3 |
| Formula Wt. | 448.45 |
| IUPAC Name | (1S,2S,3S,5R)-3-[[6-(difluoromethyl)-5-fluoro-1,2,3,4-tetrahydroisoquinolin-8-yl]oxy]-5-(4-methylpyrrolo[2,3-d]pyrimidin-7-yl)cyclopentane-1,2-diol |
| Synonym | PF06939999; PRMT5-IN-3 |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Jensen-Pergakes K, Tatlock J, Maegley K, et al. SAM-competitive PRMT5 inhibitor PF-06939999 demonstrates antitumor activity in splicing dysregulated NSCLC with decreased liability of drug resistance. Mol Cancer Ther. 2022 Jan;21(1):3-15. PMID 34737197
Quinolone, antioxidant.
Bisphosphonate.
p110γ PI3K inhibitor, potential TRPC1/5/6 nega...
Macrolide; ET antagonist, proteasome inhibitor....
Antioxidant.
pan-PI3K inhibitor.
Kavalactone originally found in Piper methystic...
Epoxomicin analog; proteasome inhibitor.
Non-selective cannabinoid receptor agonist.
SIRT inhibitor.
Saponin found in Polygala.
Endogenous bombesin-related peptide, involved i...
Endogenous neuropeptide hormone, lowers extrace...
Mycotoxin produced by species of Aspergillus; D...
Endogenous peptide hormone inolved in gastric e...
Fluoroquinolone; topoisomerase IV and bacterial...
5-HT1A agonist, α1-adrenergic antagonist.
σ1/2and μ/κ/δ-OR agonist, α3β4/α4β2/α7...
Potential voltage-gated Na+ channel blocker.
Efflux pump inhibitor